context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The opening balances of current and long-term deferred revenue were $ 296 million and $ 268 million, respectively, as of January 1, 2023. | text | 296 | monetaryItemType | text: <entity> 296 </entity> <entity type> monetaryItemType </entity type> <context> The opening balances of current and long-term deferred revenue were $ 296 million and $ 268 million, respectively, as of January 1, 2023. </context> | us-gaap:ContractWithCustomerLiabilityCurrent |
The opening balances of current and long-term deferred revenue were $ 296 million and $ 268 million, respectively, as of January 1, 2023. | text | 268 | monetaryItemType | text: <entity> 268 </entity> <entity type> monetaryItemType </entity type> <context> The opening balances of current and long-term deferred revenue were $ 296 million and $ 268 million, respectively, as of January 1, 2023. </context> | us-gaap:ContractWithCustomerLiabilityNoncurrent |
In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. | text | 920 | monetaryItemType | text: <entity> 920 </entity> <entity type> monetaryItemType </entity type> <context> In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. </context> | us-gaap:DebtInstrumentFaceAmount |
In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. | text | 0.125 | percentItemType | text: <entity> 0.125 </entity> <entity type> percentItemType </entity type> <context> In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. | text | 908 | monetaryItemType | text: <entity> 908 </entity> <entity type> monetaryItemType </entity type> <context> In September 2020, the Company issued $ 920 million aggregate principal amount of 0.125 % convertible senior notes due 2025. The net proceeds from the issuance of the Notes were $ 908 million after deducting underwriting fees and offering costs. </context> | us-gaap:ProceedsFromConvertibleDebt |
The Notes have a conversion rate of 6.9440 Class A subordinate voting shares per one thousand dollars of principal amount of Notes, which is equivalent to a conversion price of approximately $ 144.01 per share, adjusted to give effect to the Share Split. The conversion rate is subject to adjustment following the occurrence of certain specified events, as set out or defined in the supplemental indenture governing the Notes. In addition, upon the occurrence of a make-whole fundamental change prior to the maturity date or upon our issuance of a notice of redemption, as set out or defined in the supplemental indenture governing the Notes, the Company will, in certain circumstances, increase the conversion rate by a number of additional Class A subordinate voting shares for a holder that elects to convert its Notes in connection with such make-whole fundamental change or during the relevant redemption period. | text | 144.01 | perShareItemType | text: <entity> 144.01 </entity> <entity type> perShareItemType </entity type> <context> The Notes have a conversion rate of 6.9440 Class A subordinate voting shares per one thousand dollars of principal amount of Notes, which is equivalent to a conversion price of approximately $ 144.01 per share, adjusted to give effect to the Share Split. The conversion rate is subject to adjustment following the occurrence of certain specified events, as set out or defined in the supplemental indenture governing the Notes. In addition, upon the occurrence of a make-whole fundamental change prior to the maturity date or upon our issuance of a notice of redemption, as set out or defined in the supplemental indenture governing the Notes, the Company will, in certain circumstances, increase the conversion rate by a number of additional Class A subordinate voting shares for a holder that elects to convert its Notes in connection with such make-whole fundamental change or during the relevant redemption period. </context> | us-gaap:DebtInstrumentConvertibleConversionPrice1 |
during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; | text | 20 | integerItemType | text: <entity> 20 </entity> <entity type> integerItemType </entity type> <context> during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdTradingDays |
during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; | text | 30 | integerItemType | text: <entity> 30 </entity> <entity type> integerItemType </entity type> <context> during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 |
during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; | text | 130 | percentItemType | text: <entity> 130 </entity> <entity type> percentItemType </entity type> <context> during any calendar quarter commencing after March 31, 2021, and only during such calendar quarter, if the last reported sale price of the Class A subordinate voting shares on the New York Stock Exchange (the "NYSE") for at least 20 trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is more than or equal to 130 % of the conversion price for the Notes on each applicable trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger |
during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; | text | ten | integerItemType | text: <entity> ten </entity> <entity type> integerItemType </entity type> <context> during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdTradingDays |
during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; | text | ten | integerItemType | text: <entity> ten </entity> <entity type> integerItemType </entity type> <context> during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 |
during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; | text | 98 | percentItemType | text: <entity> 98 </entity> <entity type> percentItemType </entity type> <context> during the ten business day period after any ten consecutive trading day period in which, for each trading day of that period, the trading price per one thousand dollars principal amount of Notes for each trading day was less than 98 % of the product of the last reported sale price of the Class A subordinate voting shares on the NYSE and the conversion rate for the Notes on each such trading day; </context> | us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger |
On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. | text | 130 | percentItemType | text: <entity> 130 </entity> <entity type> percentItemType </entity type> <context> On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. </context> | us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger |
On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. | text | 20 | integerItemType | text: <entity> 20 </entity> <entity type> integerItemType </entity type> <context> On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. </context> | us-gaap:DebtInstrumentConvertibleThresholdTradingDays |
On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. | text | 30 | integerItemType | text: <entity> 30 </entity> <entity type> integerItemType </entity type> <context> On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. </context> | us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 |
On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> On or after September 15, 2023, the Company may, at its option, redeem for cash all or any portion of the Notes if the last reported sale price of the Company's Class A subordinate voting shares on the NYSE has been at least 130 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No "sinking fund" is provided for the Notes. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may redeem for cash all, but not less than all, of the Notes at any time if less than $ 80 million aggregate principal amount of Notes remains outstanding at such time, at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company may redeem for cash all, but not less than all, of the Notes at any time if less than $ 80 million aggregate principal amount of Notes remains outstanding at such time, at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may redeem all, but not less than all, of the Notes if the Company has or would become obligated to pay to the holder of any Note additional amounts (which are more than a de minimis amount) as a result of a change in applicable Canadian tax laws or regulations after September 15, 2020 at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest (including additional interest, if any) to, but excluding, the applicable redemption date but without reduction for applicable Canadian taxes (except in respect of certain excluded holders). | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company may redeem all, but not less than all, of the Notes if the Company has or would become obligated to pay to the holder of any Note additional amounts (which are more than a de minimis amount) as a result of a change in applicable Canadian tax laws or regulations after September 15, 2020 at a redemption price equal to 100 % of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest (including additional interest, if any) to, but excluding, the applicable redemption date but without reduction for applicable Canadian taxes (except in respect of certain excluded holders). </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
Upon the occurrence of a fundamental change (as set out or defined in the supplemental indenture governing the Notes) prior to the maturity date of the Notes, the Company, subject to limited exceptions, will be required to offer to purchase all of the Notes for cash at a price equal to 100 % of the principal amount thereof, plus any accrued and unpaid interest thereon to, but excluding, the fundamental change purchase date. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> Upon the occurrence of a fundamental change (as set out or defined in the supplemental indenture governing the Notes) prior to the maturity date of the Notes, the Company, subject to limited exceptions, will be required to offer to purchase all of the Notes for cash at a price equal to 100 % of the principal amount thereof, plus any accrued and unpaid interest thereon to, but excluding, the fundamental change purchase date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Notes are governed by customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25 % in aggregate principal amount of the Notes then outstanding may declare 100 % of the principal of, and accrued and unpaid interest on, all the Notes to be due and payable immediately. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Notes are governed by customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25 % in aggregate principal amount of the Notes then outstanding may declare 100 % of the principal of, and accrued and unpaid interest on, all the Notes to be due and payable immediately. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company accounts for the Notes as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes, less total offering costs, plus any amortization of offering costs. Total offering costs upon issuance of the Notes were $ 12 million and are amortized to interest expense using the effective interest rate method over the contractual term of the Notes. Interest expense is recognized at an annual effective interest rate of 0.38 % over the contractual term of the Notes. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> The Company accounts for the Notes as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes, less total offering costs, plus any amortization of offering costs. Total offering costs upon issuance of the Notes were $ 12 million and are amortized to interest expense using the effective interest rate method over the contractual term of the Notes. Interest expense is recognized at an annual effective interest rate of 0.38 % over the contractual term of the Notes. </context> | us-gaap:DeferredFinanceCostsGross |
The Company accounts for the Notes as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes, less total offering costs, plus any amortization of offering costs. Total offering costs upon issuance of the Notes were $ 12 million and are amortized to interest expense using the effective interest rate method over the contractual term of the Notes. Interest expense is recognized at an annual effective interest rate of 0.38 % over the contractual term of the Notes. | text | 0.38 | percentItemType | text: <entity> 0.38 </entity> <entity type> percentItemType </entity type> <context> The Company accounts for the Notes as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes, less total offering costs, plus any amortization of offering costs. Total offering costs upon issuance of the Notes were $ 12 million and are amortized to interest expense using the effective interest rate method over the contractual term of the Notes. Interest expense is recognized at an annual effective interest rate of 0.38 % over the contractual term of the Notes. </context> | us-gaap:DebtInstrumentInterestRateEffectivePercentage |
In the third quarter of 2022, a jury in the U.S. District Court for the District of Delaware returned a verdict finding that the Company infringed three web technology patents owned by Express Mobile, Inc. and the Company recorded an estimated liability in that period for damages and potential interest of $ 55 million. The Company filed a post-trial motion for judgment as a matter of law. In the second quarter of 2024, the court granted that motion, vacating the jury verdict in its entirety and mooting the plaintiff's motion for pre- and post-judgement interest. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> In the third quarter of 2022, a jury in the U.S. District Court for the District of Delaware returned a verdict finding that the Company infringed three web technology patents owned by Express Mobile, Inc. and the Company recorded an estimated liability in that period for damages and potential interest of $ 55 million. The Company filed a post-trial motion for judgment as a matter of law. In the second quarter of 2024, the court granted that motion, vacating the jury verdict in its entirety and mooting the plaintiff's motion for pre- and post-judgement interest. </context> | us-gaap:LossContingencyPatentsFoundInfringedNumber |
In the third quarter of 2022, a jury in the U.S. District Court for the District of Delaware returned a verdict finding that the Company infringed three web technology patents owned by Express Mobile, Inc. and the Company recorded an estimated liability in that period for damages and potential interest of $ 55 million. The Company filed a post-trial motion for judgment as a matter of law. In the second quarter of 2024, the court granted that motion, vacating the jury verdict in its entirety and mooting the plaintiff's motion for pre- and post-judgement interest. | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> In the third quarter of 2022, a jury in the U.S. District Court for the District of Delaware returned a verdict finding that the Company infringed three web technology patents owned by Express Mobile, Inc. and the Company recorded an estimated liability in that period for damages and potential interest of $ 55 million. The Company filed a post-trial motion for judgment as a matter of law. In the second quarter of 2024, the court granted that motion, vacating the jury verdict in its entirety and mooting the plaintiff's motion for pre- and post-judgement interest. </context> | us-gaap:LossContingencyAccrualAtCarryingValue |
The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. </context> | us-gaap:Revenues |
The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. </context> | us-gaap:SellingAndMarketingExpense |
The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a commercial agreement with Flexport, a company in which it has an equity method investment. The Company earns a share of revenues for orders processed or otherwise sent through services provided by Shopify. The Company recognized $ nil revenue in the years ended December 31, 2024, related to this agreement. In the first quarter of 2024, the Company commenced a separate agreement with Flexport to provide co-marketing services for the coordinated marketing of fulfillment-related products and services to current and prospective merchants. In the year ended December 31, 2024, the Company recognized $ 4 million of expense in the consolidated statement of operations and comprehensive income (loss) and $ 11 million in "Other current assets" in the consolidated balance sheets related to this agreement. </context> | us-gaap:OtherAssetsCurrent |
In December 2023, the Company made a separate investment in Flexport with the purchase of convertible notes of $ 260 million. The Company has selected to account for it using the fair value option for the investment, which is classified within "Equity and other investments". In the year ended December 31, 2024, the Company recognized $ 32 million of interest income related to the convertible note within "Interest income" and an immaterial amount of unrealized losses in the consolidated statement of operations and comprehensive income (loss), resulting in a fair value of $ 291 million as of December 31, 2024. | text | 32 | monetaryItemType | text: <entity> 32 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, the Company made a separate investment in Flexport with the purchase of convertible notes of $ 260 million. The Company has selected to account for it using the fair value option for the investment, which is classified within "Equity and other investments". In the year ended December 31, 2024, the Company recognized $ 32 million of interest income related to the convertible note within "Interest income" and an immaterial amount of unrealized losses in the consolidated statement of operations and comprehensive income (loss), resulting in a fair value of $ 291 million as of December 31, 2024. </context> | us-gaap:InterestIncomeExpenseNonoperatingNet |
In December 2023, the Company made a separate investment in Flexport with the purchase of convertible notes of $ 260 million. The Company has selected to account for it using the fair value option for the investment, which is classified within "Equity and other investments". In the year ended December 31, 2024, the Company recognized $ 32 million of interest income related to the convertible note within "Interest income" and an immaterial amount of unrealized losses in the consolidated statement of operations and comprehensive income (loss), resulting in a fair value of $ 291 million as of December 31, 2024. | text | 291 | monetaryItemType | text: <entity> 291 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, the Company made a separate investment in Flexport with the purchase of convertible notes of $ 260 million. The Company has selected to account for it using the fair value option for the investment, which is classified within "Equity and other investments". In the year ended December 31, 2024, the Company recognized $ 32 million of interest income related to the convertible note within "Interest income" and an immaterial amount of unrealized losses in the consolidated statement of operations and comprehensive income (loss), resulting in a fair value of $ 291 million as of December 31, 2024. </context> | us-gaap:EquityMethodInvestmentsFairValueDisclosure |
The Company is authorized to issue an unlimited number of Class A subordinate voting shares, an unlimited number of Class B restricted voting shares and one Founder share. The Class A subordinate voting shares have one vote per share, the Class B restricted voting shares have 10 votes per share and the Founder share has a variable number of votes per share. The Class B restricted voting shares are convertible into Class A subordinate voting shares on a one -for-one basis at the option of the holder. Class B restricted voting shares will also automatically convert into Class A subordinate voting shares in certain other circumstances. The Founder share cannot convert into either Class A subordinate voting shares or Class B restricted voting shares. | text | one | sharesItemType | text: <entity> one </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue an unlimited number of Class A subordinate voting shares, an unlimited number of Class B restricted voting shares and one Founder share. The Class A subordinate voting shares have one vote per share, the Class B restricted voting shares have 10 votes per share and the Founder share has a variable number of votes per share. The Class B restricted voting shares are convertible into Class A subordinate voting shares on a one -for-one basis at the option of the holder. Class B restricted voting shares will also automatically convert into Class A subordinate voting shares in certain other circumstances. The Founder share cannot convert into either Class A subordinate voting shares or Class B restricted voting shares. </context> | us-gaap:CommonStockSharesAuthorized |
The LTIP provides for the grant of share units, or LTIP Units, consisting of RSUs, performance share units (PSUs) and deferred share units (DSUs). Each LTIP Unit represents the right to receive one Class A subordinate voting share in accordance with the terms of the LTIP. Unless otherwise approved by the Compensation and Talent Management Committee of the Board of Directors, RSUs granted between November 2017 and August 2022 have been approved with three-year vesting schedules, with 1/3 vesting on each anniversary following the date of grant. As a result of employee compensation plan, certain RSUs were forfeited and their associated vesting schedules were ended. For employees that allocated a portion of their new total compensation reward to obtain RSUs, the RSUs are granted quarterly and generally vest on a monthly basis over the period of three months or if allocated to the long-term equity component, generally vest over a three year period.. A PSU participant’s grant agreement will describe the performance criteria established by the Company’s Compensation and Talent Committee of the Board of Directors that must be achieved for PSUs to vest to the PSU participant, provided the participant is continuously employed by or in the Company’s service or the service or employment of any of the Company’s affiliates from the date of grant until such PSU vesting date. As of December 31, 2024, there have been no PSUs granted. DSUs are granted solely to non-employee directors of the Company, at their option, in lieu of their Board retainer fees. DSUs will vest upon a director ceasing to act as a director. | text | no | sharesItemType | text: <entity> no </entity> <entity type> sharesItemType </entity type> <context> The LTIP provides for the grant of share units, or LTIP Units, consisting of RSUs, performance share units (PSUs) and deferred share units (DSUs). Each LTIP Unit represents the right to receive one Class A subordinate voting share in accordance with the terms of the LTIP. Unless otherwise approved by the Compensation and Talent Management Committee of the Board of Directors, RSUs granted between November 2017 and August 2022 have been approved with three-year vesting schedules, with 1/3 vesting on each anniversary following the date of grant. As a result of employee compensation plan, certain RSUs were forfeited and their associated vesting schedules were ended. For employees that allocated a portion of their new total compensation reward to obtain RSUs, the RSUs are granted quarterly and generally vest on a monthly basis over the period of three months or if allocated to the long-term equity component, generally vest over a three year period.. A PSU participant’s grant agreement will describe the performance criteria established by the Company’s Compensation and Talent Committee of the Board of Directors that must be achieved for PSUs to vest to the PSU participant, provided the participant is continuously employed by or in the Company’s service or the service or employment of any of the Company’s affiliates from the date of grant until such PSU vesting date. As of December 31, 2024, there have been no PSUs granted. DSUs are granted solely to non-employee directors of the Company, at their option, in lieu of their Board retainer fees. DSUs will vest upon a director ceasing to act as a director. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The maximum number of Class A subordinate voting shares reserved for issuance, in the aggregate, under the Company's SOP and the LTIP was initially equal to 37,436,920 Class A subordinate voting shares, adjusted to give effect to Share Split. The number of Class A subordinate voting shares available for issuance, in the aggregate, under the SOP and the LTIP will be automatically increased on January 1st of each year, beginning on January 1, 2016 and ending on January 1, 2026, in an amount equal to 5 % of the aggregate number of outstanding Class A subordinate voting shares and Class B restricted voting shares on December 31st of the preceding calendar year. As of January 1, 2025, there were 475,654,042 shares available for issuance under the Company's SOP and LTIP. | text | 37436920 | sharesItemType | text: <entity> 37436920 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of Class A subordinate voting shares reserved for issuance, in the aggregate, under the Company's SOP and the LTIP was initially equal to 37,436,920 Class A subordinate voting shares, adjusted to give effect to Share Split. The number of Class A subordinate voting shares available for issuance, in the aggregate, under the SOP and the LTIP will be automatically increased on January 1st of each year, beginning on January 1, 2016 and ending on January 1, 2026, in an amount equal to 5 % of the aggregate number of outstanding Class A subordinate voting shares and Class B restricted voting shares on December 31st of the preceding calendar year. As of January 1, 2025, there were 475,654,042 shares available for issuance under the Company's SOP and LTIP. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
The maximum number of Class A subordinate voting shares reserved for issuance, in the aggregate, under the Company's SOP and the LTIP was initially equal to 37,436,920 Class A subordinate voting shares, adjusted to give effect to Share Split. The number of Class A subordinate voting shares available for issuance, in the aggregate, under the SOP and the LTIP will be automatically increased on January 1st of each year, beginning on January 1, 2016 and ending on January 1, 2026, in an amount equal to 5 % of the aggregate number of outstanding Class A subordinate voting shares and Class B restricted voting shares on December 31st of the preceding calendar year. As of January 1, 2025, there were 475,654,042 shares available for issuance under the Company's SOP and LTIP. | text | 475654042 | sharesItemType | text: <entity> 475654042 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of Class A subordinate voting shares reserved for issuance, in the aggregate, under the Company's SOP and the LTIP was initially equal to 37,436,920 Class A subordinate voting shares, adjusted to give effect to Share Split. The number of Class A subordinate voting shares available for issuance, in the aggregate, under the SOP and the LTIP will be automatically increased on January 1st of each year, beginning on January 1, 2016 and ending on January 1, 2026, in an amount equal to 5 % of the aggregate number of outstanding Class A subordinate voting shares and Class B restricted voting shares on December 31st of the preceding calendar year. As of January 1, 2025, there were 475,654,042 shares available for issuance under the Company's SOP and LTIP. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. | text | 14340 | sharesItemType | text: <entity> 14340 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber |
As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. | text | 14535048 | sharesItemType | text: <entity> 14535048 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber |
As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. | text | 87604 | sharesItemType | text: <entity> 87604 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024 14,340 of the outstanding stock options were granted under the Company's Fourth Amended and Restated Stock Option Plan ("Legacy Option Plan") and are exercisable for Class B restricted voting shares, 14,535,048 of the outstanding stock options were granted under the Company's SOP and are exercisable for Class A subordinate voting shares, and 87,604 of the outstanding stock options were granted under the Deliverr 2017 Stock Option and Grant Plan and are exercisable for Class A subordinate voting shares. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber |
As of December 31, 2024 the Company had issued 14,615 DSUs under its LTIP. | text | 14615 | sharesItemType | text: <entity> 14615 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024 the Company had issued 14,615 DSUs under its LTIP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The total intrinsic value of stock options exercised and RSUs settled during the years ended December 31, 2024 and 2023 was $ 609 million and $ 564 million, respectively. The aggregate intrinsic value of options exercised is calculated as the difference between the exercise price of the underlying stock option awards and the market value on the date of exercise. | text | 609 | monetaryItemType | text: <entity> 609 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of stock options exercised and RSUs settled during the years ended December 31, 2024 and 2023 was $ 609 million and $ 564 million, respectively. The aggregate intrinsic value of options exercised is calculated as the difference between the exercise price of the underlying stock option awards and the market value on the date of exercise. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of stock options exercised and RSUs settled during the years ended December 31, 2024 and 2023 was $ 609 million and $ 564 million, respectively. The aggregate intrinsic value of options exercised is calculated as the difference between the exercise price of the underlying stock option awards and the market value on the date of exercise. | text | 564 | monetaryItemType | text: <entity> 564 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of stock options exercised and RSUs settled during the years ended December 31, 2024 and 2023 was $ 609 million and $ 564 million, respectively. The aggregate intrinsic value of options exercised is calculated as the difference between the exercise price of the underlying stock option awards and the market value on the date of exercise. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
As of December 31, 2024 and 2023, there was $ 487 million and $ 261 million, respectively, of remaining unamortized compensation cost related to unvested stock options and RSUs granted to the Company’s employees. This cost will be recognized over an estimated weighted-average remaining period of 2.20 years. Total unamortized compensation cost will be adjusted for future changes in estimated forfeitures. | text | 487 | monetaryItemType | text: <entity> 487 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, there was $ 487 million and $ 261 million, respectively, of remaining unamortized compensation cost related to unvested stock options and RSUs granted to the Company’s employees. This cost will be recognized over an estimated weighted-average remaining period of 2.20 years. Total unamortized compensation cost will be adjusted for future changes in estimated forfeitures. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024 and 2023, there was $ 487 million and $ 261 million, respectively, of remaining unamortized compensation cost related to unvested stock options and RSUs granted to the Company’s employees. This cost will be recognized over an estimated weighted-average remaining period of 2.20 years. Total unamortized compensation cost will be adjusted for future changes in estimated forfeitures. | text | 261 | monetaryItemType | text: <entity> 261 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, there was $ 487 million and $ 261 million, respectively, of remaining unamortized compensation cost related to unvested stock options and RSUs granted to the Company’s employees. This cost will be recognized over an estimated weighted-average remaining period of 2.20 years. Total unamortized compensation cost will be adjusted for future changes in estimated forfeitures. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Company has not paid and does not anticipate paying any cash dividends in the foreseeable future and, therefore, uses an expected dividend yield of zero in the option pricing model. | text | zero | percentItemType | text: <entity> zero </entity> <entity type> percentItemType </entity type> <context> The Company has not paid and does not anticipate paying any cash dividends in the foreseeable future and, therefore, uses an expected dividend yield of zero in the option pricing model. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
The Company had a provision for income taxes of $ 209 million in the year ended December 31, 2024, on account of earnings and unrealized gains on the company's equity and other investments, net of an offset to the reversal of valuation allowance. | text | 209 | monetaryItemType | text: <entity> 209 </entity> <entity type> monetaryItemType </entity type> <context> The Company had a provision for income taxes of $ 209 million in the year ended December 31, 2024, on account of earnings and unrealized gains on the company's equity and other investments, net of an offset to the reversal of valuation allowance. </context> | us-gaap:IncomeTaxExpenseBenefit |
During the year ended December 31, 2023, the Company had a provision for income taxes of $ 53 million, primarily on account of earnings in jurisdictions outside of North America. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company had a provision for income taxes of $ 53 million, primarily on account of earnings in jurisdictions outside of North America. </context> | us-gaap:IncomeTaxExpenseBenefit |
During the year ended December 31, 2022, as a result of the application of the Company's tax rates to the results of ongoing operations, other discrete items primarily related to unrealized non-deductible losses on equity and other investments, share-based compensation and change in valuation allowance related to deferred tax assets in Canada as well as the United States, the Company had a recovery for income taxes of $ 163 million. | text | 163 | monetaryItemType | text: <entity> 163 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, as a result of the application of the Company's tax rates to the results of ongoing operations, other discrete items primarily related to unrealized non-deductible losses on equity and other investments, share-based compensation and change in valuation allowance related to deferred tax assets in Canada as well as the United States, the Company had a recovery for income taxes of $ 163 million. </context> | us-gaap:IncomeTaxExpenseBenefit |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 117 | monetaryItemType | text: <entity> 117 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 306 | monetaryItemType | text: <entity> 306 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 383 | monetaryItemType | text: <entity> 383 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 339 | monetaryItemType | text: <entity> 339 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 272 | monetaryItemType | text: <entity> 272 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 333 | monetaryItemType | text: <entity> 333 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 761 | monetaryItemType | text: <entity> 761 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsCapitalLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:DeferredTaxAssetsCapitalLossCarryforwards |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 226 | monetaryItemType | text: <entity> 226 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. | text | 104 | monetaryItemType | text: <entity> 104 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had Canadian unused non-capital tax losses of approximately $ 5 million and $ 117 million, respectively. As of December 31, 2024 and 2023, the Company had U.S. federal unused non-capital tax losses of approximately $ 306 million and $ 383 million, respectively. In addition, as of December 31, 2024 and 2023, the Company had unused non-capital tax losses in various U.S. states of approximately $ 339 million and $ 1.5 billion, respectively. As of December 31, 2024, $ 272 million and $ 6 million of the federal and state non-capital tax losses, respectively, have no expiry. The remaining unused federal and state non-capital tax losses of $ 34 million and $ 333 million, respectively, will begin to expire starting in 2031. As of December 31, 2024, the Company also has $ 761 million of capital losses in Canada that do not expire as well as $ 1.7 billion of capital losses in the U.S. that expires in 2028. In addition, as of December 31, 2024 and 2023, the Company had an undeducted Canadian research and development expenditure balance totaling $ nil and $ 226 million, respectively. As of December 31, 2024 and 2023, the Company had Canadian and U.S. federal and state tax credits of $ 33 million and $ 104 million, respectively. The unused U.S. federal tax credits will begin to expire in 2042 and the unused U.S. state research and development credits will begin to expire starting in 2029. The unused Canadian investment tax credits will begin to expire starting in 2043. </context> | us-gaap:TaxCreditCarryforwardAmount |
In May 2023, the Company reduced headcount by approximately 23 % of employees across the Company ("2023 Reduction in Workforce"). The Company incurred and paid $ 148 million in total severance related costs in the year ended December 31, 2023. | text | 23 | percentItemType | text: <entity> 23 </entity> <entity type> percentItemType </entity type> <context> In May 2023, the Company reduced headcount by approximately 23 % of employees across the Company ("2023 Reduction in Workforce"). The Company incurred and paid $ 148 million in total severance related costs in the year ended December 31, 2023. </context> | us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent |
In May 2023, the Company reduced headcount by approximately 23 % of employees across the Company ("2023 Reduction in Workforce"). The Company incurred and paid $ 148 million in total severance related costs in the year ended December 31, 2023. | text | 148 | monetaryItemType | text: <entity> 148 </entity> <entity type> monetaryItemType </entity type> <context> In May 2023, the Company reduced headcount by approximately 23 % of employees across the Company ("2023 Reduction in Workforce"). The Company incurred and paid $ 148 million in total severance related costs in the year ended December 31, 2023. </context> | us-gaap:SeveranceCosts1 |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | ten | integerItemType | text: <entity> ten </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | 56 | percentItemType | text: <entity> 56 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. | text | 93 | percentItemType | text: <entity> 93 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, all of our properties and development and redevelopment projects, and all of our business was conducted in the state of California, with the exception of ten stabilized office properties and one future development project located in the state of Washington, and one stabilized office property and one future development project located in Austin, Texas. All of our properties and development and redevelopment projects are 100 % owned, excluding four office properties owned by three consolidated property partnerships. Two of the three consolidated property partnerships, 100 First Street Member, LLC (“100 First LLC”) and 303 Second Street Member, LLC (“303 Second LLC”), each owned one office property in San Francisco, California through subsidiary REITs. As of December 31, 2024, the Company owned a 56 % common equity interest in both 100 First LLC and 303 Second LLC. The third consolidated property partnership, Redwood City Partners, LLC (“Redwood LLC”), owned two office properties in Redwood City, California. As of December 31, 2024, the Company owned an approximate 93 % common equity interest in Redwood LLC. The remaining interests in all three property partnerships were owned by unrelated third parties. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
As of December 31, 2024, the Company owned an approximate 99.0 % common general partnership interest in the Operating Partnership. The remaining approximate 1.0 % common limited partnership interest in the Operating Partnership as of December 31, 2024 was owned by non-affiliated investors and a former executive officer and director. Both the general and limited common partnership interests in the Operating Partnership are denominated in common units. Generally, the number of common units held by the Company is equivalent to the number of outstanding shares of the Company’s common stock, and the rights of all the common units to quarterly distributions and payments in liquidation mirror those of the Company’s common stockholders. The common limited partners have certain redemption rights as provided in the Operating Partnership’s Seventh Amended and Restated Agreement of Limited Partnership, as amended (the “Partnership Agreement”). With the exception of the Operating Partnership and our consolidated property partnerships, all of our subsidiaries are wholly-owned. | text | 1.0 | percentItemType | text: <entity> 1.0 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, the Company owned an approximate 99.0 % common general partnership interest in the Operating Partnership. The remaining approximate 1.0 % common limited partnership interest in the Operating Partnership as of December 31, 2024 was owned by non-affiliated investors and a former executive officer and director. Both the general and limited common partnership interests in the Operating Partnership are denominated in common units. Generally, the number of common units held by the Company is equivalent to the number of outstanding shares of the Company’s common stock, and the rights of all the common units to quarterly distributions and payments in liquidation mirror those of the Company’s common stockholders. The common limited partners have certain redemption rights as provided in the Operating Partnership’s Seventh Amended and Restated Agreement of Limited Partnership, as amended (the “Partnership Agreement”). With the exception of the Operating Partnership and our consolidated property partnerships, all of our subsidiaries are wholly-owned. </context> | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 435.5 | monetaryItemType | text: <entity> 435.5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Assets |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 357.3 | monetaryItemType | text: <entity> 357.3 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Assets |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 18.0 | monetaryItemType | text: <entity> 18.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Liabilities |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 169.4 | monetaryItemType | text: <entity> 169.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 416.7 | monetaryItemType | text: <entity> 416.7 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Assets |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 350.0 | monetaryItemType | text: <entity> 350.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Assets |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 23.6 | monetaryItemType | text: <entity> 23.6 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:Liabilities |
At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. | text | 173.7 | monetaryItemType | text: <entity> 173.7 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the consolidated financial statements of the Company included three VIEs in addition to the Operating Partnership: 100 First LLC, 303 Second LLC, and one entity established during the third quarter of 2024 to facilitate a potential future Section 1031 Exchange. At December 31, 2024, the Company and the Operating Partnership were determined to be the primary beneficiaries of these three VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. As of December 31, 2024, the three VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 435.5 million (of which $ 357.3 million related to real estate held for investment), approximately $ 18.0 million, and approximately $ 169.4 million, respectively. At December 31, 2023, the consolidated financial statements of the Company included two VIEs in addition to the Operating Partnership: 100 First LLC and 303 Second LLC. At December 31, 2023, the Company and the Operating Partnership were determined to be the primary beneficiaries of these two VIEs since we had the ability to control the activities that most significantly impact each of the VIEs’ economic performance. At December 31, 2023 the two VIEs’ total assets, liabilities, and noncontrolling interests included on our consolidated balance sheet were approximately $ 416.7 million (of which $ 350.0 million related to real estate held for investment on our consolidated balance sheet), approximately $ 23.6 million, and approximately $ 173.7 million, respectively. Revenues, income, and net assets generated by 100 First LLC and 303 Second LLC may only be used to settle their contractual obligations, which primarily consist of operating expenses, capital expenditures, and required distributions. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
Transaction costs associated with our acquisitions, including costs incurred during negotiation, are capitalized as part of the purchase price of the acquisition. During the years ended December 31, 2024 and 2022, we capitalized $ 0.2 million of acquisition costs. We did no t capitalize any acquisition costs during the year ended December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Transaction costs associated with our acquisitions, including costs incurred during negotiation, are capitalized as part of the purchase price of the acquisition. During the years ended December 31, 2024 and 2022, we capitalized $ 0.2 million of acquisition costs. We did no t capitalize any acquisition costs during the year ended December 31, 2023. </context> | us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts |
The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. | text | 308.0 | monetaryItemType | text: <entity> 308.0 </entity> <entity type> monetaryItemType </entity type> <context> The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. </context> | us-gaap:Depreciation |
The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. | text | 300.1 | monetaryItemType | text: <entity> 300.1 </entity> <entity type> monetaryItemType </entity type> <context> The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. </context> | us-gaap:Depreciation |
The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. | text | 287.8 | monetaryItemType | text: <entity> 287.8 </entity> <entity type> monetaryItemType </entity type> <context> The costs of buildings and improvements and tenant improvements are depreciated using the straight-line method of accounting over the estimated useful lives set forth in the table below. Depreciation expense for buildings and improvements for the three years ended December 31, 2024, 2023, and 2022 was $ 308.0 million, $ 300.1 million, and $ 287.8 million, respectively. </context> | us-gaap:Depreciation |
We currently operate as one reportable segment. See Note 26 “Segments” for additional information. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We currently operate as one reportable segment. See Note 26 “Segments” for additional information. </context> | us-gaap:NumberOfOperatingSegments |
Represents below-market leases (approximately $ 0.3 million with a weighted average amortization period of 4.9 years). | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> Represents below-market leases (approximately $ 0.3 million with a weighted average amortization period of 4.9 years). </context> | us-gaap:BelowMarketLeaseAcquired |
The total gain on the sale of the operating property sold during the year ended December 31, 2022 was $ 17.3 million. | text | 17.3 | monetaryItemType | text: <entity> 17.3 </entity> <entity type> monetaryItemType </entity type> <context> The total gain on the sale of the operating property sold during the year ended December 31, 2022 was $ 17.3 million. </context> | us-gaap:GainLossOnSaleOfPropertyPlantEquipment |
During the year ended December 31, 2024, the Company sold its corporate aircraft, which was included in furniture, fixtures, and other long-lived assets, net, for a sales price of $ 19.8 million, and recognized a gain on sale of approximately $ 6.0 million. | text | 19.8 | monetaryItemType | text: <entity> 19.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company sold its corporate aircraft, which was included in furniture, fixtures, and other long-lived assets, net, for a sales price of $ 19.8 million, and recognized a gain on sale of approximately $ 6.0 million. </context> | us-gaap:ProceedsFromSaleOfOtherAssets1 |
During the year ended December 31, 2024, the Company sold its corporate aircraft, which was included in furniture, fixtures, and other long-lived assets, net, for a sales price of $ 19.8 million, and recognized a gain on sale of approximately $ 6.0 million. | text | 6.0 | monetaryItemType | text: <entity> 6.0 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company sold its corporate aircraft, which was included in furniture, fixtures, and other long-lived assets, net, for a sales price of $ 19.8 million, and recognized a gain on sale of approximately $ 6.0 million. </context> | us-gaap:GainLossOnSaleOfOtherAssets |
The Company generally guarantees all of the Operating Partnership’s unsecured debt obligations, including the unsecured revolving credit facility, the unsecured term loan facility, and all of the unsecured senior notes. At December 31, 2024 and 2023, the Operating Partnership had $ 4.0 billion and $ 4.3 billion, respectively, outstanding in total, including unamortized discounts and deferred financing costs, under these unsecured debt obligations. | text | 4.0 | monetaryItemType | text: <entity> 4.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company generally guarantees all of the Operating Partnership’s unsecured debt obligations, including the unsecured revolving credit facility, the unsecured term loan facility, and all of the unsecured senior notes. At December 31, 2024 and 2023, the Operating Partnership had $ 4.0 billion and $ 4.3 billion, respectively, outstanding in total, including unamortized discounts and deferred financing costs, under these unsecured debt obligations. </context> | us-gaap:LongTermDebt |
The Company generally guarantees all of the Operating Partnership’s unsecured debt obligations, including the unsecured revolving credit facility, the unsecured term loan facility, and all of the unsecured senior notes. At December 31, 2024 and 2023, the Operating Partnership had $ 4.0 billion and $ 4.3 billion, respectively, outstanding in total, including unamortized discounts and deferred financing costs, under these unsecured debt obligations. | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company generally guarantees all of the Operating Partnership’s unsecured debt obligations, including the unsecured revolving credit facility, the unsecured term loan facility, and all of the unsecured senior notes. At December 31, 2024 and 2023, the Operating Partnership had $ 4.0 billion and $ 4.3 billion, respectively, outstanding in total, including unamortized discounts and deferred financing costs, under these unsecured debt obligations. </context> | us-gaap:LongTermDebt |
During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. | text | 3.450 | percentItemType | text: <entity> 3.450 </entity> <entity type> percentItemType </entity type> <context> During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. | text | 403.7 | monetaryItemType | text: <entity> 403.7 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. </context> | us-gaap:DebtInstrumentCarryingAmount |
During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. | text | 403.7 | monetaryItemType | text: <entity> 403.7 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company completed open-market repurchases of $ 21.3 million of the Operating Partnership’s 3.450 % $ 425.0 million unsecured senior notes due December 15, 2024 at a discount, leaving an aggregate remaining principal balance of $ 403.7 million. In December 2024, the Company repaid the aggregate remaining principal balance of $ 403.7 million senior notes on the maturity date. </context> | us-gaap:RepaymentsOfUnsecuredDebt |
Issuance of $ 400.0 million Unsecured Senior Notes Due 2036 | text | 400.0 | monetaryItemType | text: <entity> 400.0 </entity> <entity type> monetaryItemType </entity type> <context> Issuance of $ 400.0 million Unsecured Senior Notes Due 2036 </context> | us-gaap:DebtInstrumentFaceAmount |
In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. | text | 400.0 | monetaryItemType | text: <entity> 400.0 </entity> <entity type> monetaryItemType </entity type> <context> In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. </context> | us-gaap:DebtInstrumentCarryingAmount |
In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. </context> | us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet |
In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> In January 2024, the Operating Partnership issued $ 400.0 million aggregate principal amount of unsecured senior notes in a registered public offering. The outstanding balance of the unsecured senior notes is included in unsecured debt, net of an initial issuance discount of $ 4.5 million, on our consolidated balance sheets. The unsecured senior notes, which are scheduled to mature on January 15, 2036, require semi-annual interest payments each January and July based on a stated annual interest rate of 6.250 %. The Operating Partnership may redeem the notes at any time, either in whole or in part, subject to the payment of an early redemption premium with respect to redemptions prior to October 15, 2035. On or after October 15, 2035, the Operating Partnership may redeem the notes at any time, either in whole or in part, at par. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The following table summarizes the balance and significant terms of the registered unsecured senior notes issued by the Operating Partnership and outstanding, including unamortized discounts of $ 8.4 million | text | 8.4 | monetaryItemType | text: <entity> 8.4 </entity> <entity type> monetaryItemType </entity type> <context> The following table summarizes the balance and significant terms of the registered unsecured senior notes issued by the Operating Partnership and outstanding, including unamortized discounts of $ 8.4 million </context> | us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet |
and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: | text | 5.3 | monetaryItemType | text: <entity> 5.3 </entity> <entity type> monetaryItemType </entity type> <context> and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: </context> | us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet |
and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: | text | 15.8 | monetaryItemType | text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: </context> | us-gaap:UnamortizedDebtIssuanceExpense |
and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: | text | 15.9 | monetaryItemType | text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> and $ 5.3 million and unamortized deferred financing costs of $ 15.8 million and $ 15.9 million as of December 31, 2024 and 2023, respectively: </context> | us-gaap:UnamortizedDebtIssuanceExpense |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.